تولید ژلاتین کپسول ایران
دکپسول | Stocks - Iran Fara Bourse (IFB)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 192,300 3.00
Close Price: 191,900
Income Statement
AGM
Interim
2026/06/28 Fiscal Year 2026/03/2012 Month | 2025/05/04 Fiscal Year 2025/03/2012 Month | 2024/05/05 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 14.718 Trillion | 10.346 Trillion | 7.493 Trillion | |
Total Revenues | 14.718 Trillion | 10.346 Trillion | 7.493 Trillion | |
Cost of Goods Sold | 6.683 Trillion | 4.276 Trillion | 2.87 Trillion | |
Gross Profit | 8.035 Trillion | 6.07 Trillion | 4.622 Trillion | |
General & Administrative Expenses | 982.107 Billion | 631.46 Billion | 371.624 Billion | |
Net Operating Income & Expenses | 69.968 Billion | -61.373 Billion | -21.549 Billion | |
Operating Profit (Loss) | 7.123 Trillion | 5.378 Trillion | 4.229 Trillion | |
Profit Before Tax | 6.989 Trillion | 5.283 Trillion | 4.143 Trillion | |
Tax | 1.599 Trillion | 963.492 Billion | 715.71 Billion | |
Net Profit (Loss) After Tax | 5.39 Trillion | 4.319 Trillion | 3.427 Trillion | |
Retained Earnings at Beginning of Period | 5.796 Trillion | 3.877 Trillion | 2.91 Trillion | |
Approved Dividends — Prior Year AGM | -4.5 Trillion | -2.4 Trillion | -2.46 Trillion | |
Allocable Profit | 6.686 Trillion | 5.796 Trillion | 3.877 Trillion | |
Approved Dividends — Current Year | 4.98 Trillion | 4.35 Trillion | 2.4 Trillion | |
Retained Earnings at End of Period | 1.706 Trillion | 1.446 Trillion | 1.477 Trillion |